ArticleThe Journal of urology2018
Re: Germline DNA-Repair Gene Mutations and Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Receiving First-Line Abiraterone and Enzalutamide.
Samir S TanejaPubMed ↗Publisher ↗
No numbers read from the abstract.